bioRxiv Science⌕ Search

Biology subjects

Grau, A.

Publications and source records attributed to Grau, A..

2 recordsLinked to original sources

Mammalian growth-regulating factors enhance regeneration of recalcitrant transgenic tomato accessions

Genome editing is now available for many crops. It has increased our ability to study gene function and has changed the field of plant transgenesis. Nevertheless, the ability to regenerate plants from cell culture remains a limiting factor for many crops, and even for species with a good regeneration potential, some accessions remain recalcitrant. The physiological state of plant cells is involved in the process of plant growth and development and is closely linked to the network involving MAP-kinase signaling pathway. Some of the defense genes activated during the cellular repair process of transgenesis show high homologies with mammalian defense genes. We thus compared the percentage of transgenic plants obtained by CRISPR-Cas9 mutation in four genes involved in sugar and acid metabolism after supplementation with different mammalian growth factors and cytokines in six tomato accessions presenting a range of regeneration levels. We demonstrated, through three years of transgenesis experiments, that the use of mammalian growth factors during transgenesis improved regeneration rate of recalcitrant tomato accessions. We demonstrated that using cytokines not only improved transformation of difficult-to-transform accessions but also the production rate of stable secondary lines. Summary statementSupplementation of transformation medium with mammalian growth-regulating factors enhanced regeneration of tomato recalcitrant genotypes

plant biology↗

Systems level analysis of B-cell development identifies BDNF as a driver for human B lymphopoiesis

B-cell aplasia is a major consequence of aging, chemotherapy, and B-cell-depleting immunotherapies, compromising immune protection against infections, cancer, and vaccines. Yet, unlike the myeloid and erythroid lineages, no strategy exists to accelerate human B-cell reconstitution. Here, we used an integrative systems biology approach to identify regulators of human B lymphopoiesis in the bone marrow (BM) microenvironment. By combining single-cell transcriptomic analysis of human BM with intercellular communication mapping, we generated an initial set of candidate factors predicted to act on developing B cells. To distinguish biologically meaningful putative regulators from a broad candidate space, we further intersected these findings with orthogonal human datasets capturing age-impaired B lymphopoiesis and protein dynamics associated with B-cell depletion and reconstitution. This convergent prioritization strategy highlighted a focused set of putative regulators, among which brain-derived neurotrophic factor (BDNF) emerged repeatedly as a top putative regulator. Functional interrogation in progenitor BM cells showed that several prioritized putative regulators induced transcriptional programs linked to early immune development, with BDNF consistently promoting pathways associated with B-cell differentiation. Importantly, in a human in vitro BM co-culture system, BDNF enhanced the differentiation of CD34+ hematopoietic progenitors into CD19+ progenitor B cells. Together, these findings identify BDNF as a previously unrecognized regulator of early human B lymphopoiesis and establish a general framework for uncovering functional hematopoietic regulators by integrating single-cell analysis with complementary biological and clinical signals. This approach may support future strategies to improve immune reconstitution in settings of prolonged B-cell depletion.

systems biology↗